Regenxbio (RGNX) Interest & Investment Income (2015 - 2026)
Regenxbio (RGNX) posted quarterly Interest & Investment Income of -$35000.0 for Q4 2025, up 99.37% year-over-year from -$17555.6 in Q4 2024, and down 135.71% quarter-over-quarter from $98000.0 in Q3 2025.
Regenxbio (RGNX) Interest & Investment Income (2015 - 2026) Analysis & Trends
Regenxbio's Interest & Investment Income history runs 11 years deep, the most recent figure standing at -$35000.0 for Q4 2025.
- In Q4 2025, Interest & Investment Income rose 99.37% year-over-year to -$35000.0; the TTM figure through Dec 2025 stood at $3.4 million (down 7.24% YoY), while the FY2025 annual figure was $54000.0, down 98.54% from the prior year.
- Interest & Investment Income for Q4 2025 stood at -$35000.0, down from $98000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $7.8 million in Q4 2021, with the low at -$9.4 million in Q1 2022.
- The 5-year median for Interest & Investment Income is $1.8 million (2022), against an average of $807950.0.
- Peak annual rise in Interest & Investment Income reached 5090.0% in 2022, while the deepest fall reached 830.65% in 2022.
- Regenxbio's Interest & Investment Income stood at $7.8 million in 2021, then plunged by 73.86% to $2.0 million in 2022, then retreated by 0.35% to $2.0 million in 2023, then plunged by 373.65% to -$5.5 million in 2024, then surged by 99.37% to -$35000.0 in 2025.
- Business Quant data shows RGNX's Interest & Investment Income at -$35000.0 in Q4 2025, $98000.0 in Q3 2025, and $3.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn | 1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.22 Mn |
| Dec 31, 2025 | -35,000.00 |
| Sep 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 3.38 Mn |
| Mar 31, 2025 | -21,000.00 |
| Dec 31, 2024 | -5.53 Mn |
| Sep 30, 2024 | 3.28 Mn |
| Jun 30, 2024 | 3.47 Mn |
| Mar 31, 2024 | 2.47 Mn |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 2.69 Mn |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | 3.78 Mn |
| Dec 31, 2022 | 2.03 Mn |
| Sep 30, 2022 | 1.50 Mn |
| Jun 30, 2022 | -2.81 Mn |
| Mar 31, 2022 | -9.38 Mn |
| Dec 31, 2021 | 7.75 Mn |
| Sep 30, 2021 | -30,000.00 |
| Jun 30, 2021 | 399,000.00 |